Showing all publications

Pages

Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort.

Doyle JS; Deterding K; Grebely J; Wedemeyer H; Sacks-Davis R; Spelman T; Matthews G; Rice TM; Morris MD; McGovern BH; Kim AY; Bruneau J; Lloyd AR; Page K; Manns MP; Hellard ME; Dore GJ.
, 2015.

Risk charts to guide targeted HIV-1 viral load monitoring of ART: development and validation in patients from resource-limited settings.

Koller M; Fatti G; Chi BH; Keiser O; Hoffmann CJ; Wood R; Prozesky H; Stinson K; Giddy J; Mutevedzi P; Fox M; Law M; Boulle A; Egger M.
, 2015.

Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.

Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J.
, 2015.

Attendance patterns and chlamydia and gonorrhoea testing among young people in Aboriginal primary health centres in New South Wales, Australia

Graham S; Wand HC; Ward JS; Knox J; McCowen D; Bullen P; Booker J; O'Brien C; Garrett K; Donovan B; Kaldor J; Guy RJ.
, 2015.

Reasons for delays in treatment of bacterial sexually transmissible infections in remote Aboriginal communities in Australia: A qualitative study of healthcentre staff

Hengel B; Maher L; Garton L; Ward J; Rumbold A; Taylor-Thomson D; Silver B; Mcgregor S; Dyda A; Knox J; Kaldor J; Guy R.
, 2015.

Pages